FRANKFURT (Reuters) -Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion (NASDAQ:ALXN) Pharmaceuticals for $39 billion in its largest ever deal, diversifying away from its fast-growing cancer business in a…
Trending News
January 4, 2025
December 27, 2024
December 20, 2024
November 19, 2024
July 10, 2024